CORPORATE DEVELOPMENT, COO

Simon Fricker, PhD

WntRx's team is comprised of world-leading cancer researchers and biotech industry innovators whose work lies at the forefront of cancer therapeutics development. Management is guided by distinguished advisors, including industry leaders and highly experienced investors and entrepreneurs.

Advisors

• Immuno-oncology at Aleta, Biogen, and X-Rx

• 20+ years of experience in business development

• ​Formerly at Johnson and Johnson, ImmunoGen, Anchor, and Oxyrane
  

Daniel Geffken, MBA

Paul D. Rennert, PhD

Jin (Jim) Wang

John Tagliamonte, MBA

CFO (PART-TIME)

• Investment Director at Jianxin Capital

CO-FOUNDER, CBO (PART-TIME)

Management

Robert Perni, PhD

EXECUTIVE CHAIRMAN

• Cancer biology at AnorMed and Genzyme

Team

• Chemistry at Vertex Pharmaceuticals

Yeung Heung Yeung, PhD

• President of Venture Leader Group

• Former President of TEEC Angel Fund 

• Executive Vice President of Technology and Research, Microsoft

• Managing Director at Danforth Advisors with deep financial expertise

Eric Cheng, MD, MBA

• 20+ years of experience in founding, investing, and managing innovative therapeutic R&D companies